New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X

Abstract EPNs comprise a heterogeneous group of neuroepithelial tumors, accounting for about 10% of all intracranial tumors in children and up to 30% of brain tumors in those younger than 3 years. Actually, the pattern therapy for low-grade EPNs includes complete surgical resection followed by radia...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lorena Favaro Pavon, David Capper, Tatiana Tais Sibov, Silvia Regina Caminada de Toledo, Ulrich-W. Thomale, Jean Gabriel de Souza, Francisco Romero Cabral, Carolina Maria Berra, Marcos Devanir Silva da Costa, Jardel Mendonça Niçacio, Patrícia Alessandra Dastoli, Daniela Mara de Oliveira, Suzana M. F. Malheiros, Edgar Ferreira da Cruz, Jackeline Moraes Malheiros, Sérgio Mascarenhas de Oliveira, Nasjla Saba Silva, Antonio Sérgio Petrilli, Andrea Maria Cappellano, Milena Colò Brunialti, Reinaldo Salomão, Manoel A. de Paiva Neto, Ana Marisa Chudzinski-Tavassi, Sérgio Cavalheiro
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2019
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/384af2c64a0143f7b07d35ffbf8a2408
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X

Ejemplares similares